Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Total Debt (2017 - 2025)

Icu Medical's Total Debt history spans 7 years, with the latest figure at $1.3 billion for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt fell 18.84% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2025, down 18.84%, and an annual FY2025 reading of $1.3 billion, down 18.84% over the prior year.
  • Total Debt for Q4 2025 was $1.3 billion at Icu Medical, down from $1.3 billion in the prior quarter.
  • The five-year high for Total Debt was $1.7 billion in Q1 2022, with the low at $26.3 million in Q1 2021.
  • Average Total Debt over 5 years is $1.3 billion, with a median of $1.6 billion recorded in 2024.
  • Year-over-year, Total Debt crashed 82.47% in 2021 and then surged 6196.52% in 2022.
  • Tracing ICUI's Total Debt over 5 years: stood at $26.3 million in 2021, then surged by 6186.55% to $1.7 billion in 2022, then fell by 1.49% to $1.6 billion in 2023, then dropped by 2.82% to $1.6 billion in 2024, then dropped by 18.84% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Total Debt are $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025).